1 |
Adams JD, Wang R, Yang J, Lien EJ. 2006. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin. Med. 1: 3.
DOI
|
2 |
Aricha B, Fishov I, Cohen Z, Sikron N, Pesakhov S, Khozin-Goldberg I, et al. 2004. Differences in membrane fluidity and fatty acid composition between phenotypic variants of Streptococcus pneumoniae. J. Bacteriol. 186: 4638-4644.
DOI
|
3 |
Carrillo-Muñoz AJ, Giusiano G, Ezkurra PA, Quindós G. 2006. Antifungal agents: mode of action in yeast cells. Rev. Esp. Quimioterap. 19: 130-139.
|
4 |
Carson CF, Mee BJ, Riley TV. 2002. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob. Agents Chemother. 46: 1914-1920.
DOI
|
5 |
Clinical Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A3, 3rd Ed. Clinical and Laboratory Standards Institute, Wayne, PA.
|
6 |
Ghannoum MA, Janini G, Khamis L, Radwan SS. 1986. Dimorphism-associated variations in the lipid composition of Candida albicans. J. Gen. Microbiol. 132: 2367-2375.
|
7 |
Cowan MM. 1999. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12: 564-582.
|
8 |
Dufourc EJ. 2008. Sterols and membrane dynamics. J. Chem. Biol. 1: 63-77.
DOI
|
9 |
Frost DJ, Brandt KD, Cugier D, Goldman R. 1995. A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J. Antibiot. 48: 306-310.
DOI
|
10 |
Gray KC, Palacios DS, Dailey I, Endo MM, Uno BE, Wilcock BC, Burke MD. 2012. Amphotericin primarily kills yeast by simply binding ergosterol. Proc. Natl. Acad. Sci. USA 109: 2234–2239.
DOI
|
11 |
Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, et al. 2008. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol. Ther. 117: 280-295.
DOI
|
12 |
Han Y, Joo I. 2013. Antifungal effect of tanshinone from Salvia miltiorrhiza against disseminated candidiasis. Yakhak Hoeji 57: 119-124.
|
13 |
Khan MSA, Ahmad I, Cameotra SS. 2013. Phenyl aldehyde and propanoids exert multiple sites of action towards cell membrane and cell wall targeting ergosterol in Candida albicans. AMB Express 3: 54.
DOI
|
14 |
Krcmery V, Barnes AJ. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50: 243-260.
DOI
|
15 |
Kurtz M, Douglas C. 1997. Lipopeptide inhibitors of fungal glucan synthase. J. Med. Vet. Mycol. 35: 79-86.
DOI
|
16 |
Li YG, Song L, Liu M, Hu ZB, Wang ZT. 2009. Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen). J. Chromatogr. A 1216: 1941-1953.
DOI
|
17 |
Lin TH, Hsieh CL. 2010. Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction. Chin. Med. 5: 22-27.
DOI
|
18 |
Liu M, Seidel V, Katerere DR, Gray AI. 2007. Colorimetric broth microdilution method for the antifungal screening of plant extracts against yeast. Methods 42: 325-329.
DOI
|
19 |
Munro S. 2003. Lipid rafts: elusive or illusive? Cell 115: 377-388.
DOI
|
20 |
Marczak A. 2009. Fluorescence anisotropy of membrane fluidity probes in human erythrocytes incubated with anthracyclines and glutaraldehyde. Bioelectrochemistry 74: 236-239.
DOI
|
21 |
Parks LW, Casey WM. 1995. Physiological implications of sterol biosynthesis in yeast. Annu. Rev. Microbiol. 49: 95-116.
DOI
|
22 |
Pfaller MA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20: 133-163.
DOI
|
23 |
Pfaller MA, Pappas PG, Wingard JR. 2006. Invasive fungal pathogens: current epidemiological trends. Clin. Infect. Dis. 43: S3-S14.
DOI
|
24 |
Repáková J, Holopainen JM, Morrow MR, McDonald MC, Capková P, Vattulainen I. 2005. Influence of DPH on the structure and dynamics of a DPPC bilayer. Biophys. J. 88: 3398-3410.
DOI
|
25 |
Shapiro HM. 1995. Parameters and probes, p. 229. In Practical Flow Cytometry, 3rd Ed. Wiley, New York.
|
26 |
Shapiro RS, Robbins N, Cowen LE. 2011. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol. Mol. Biol. Rev. 75: 213-267.
DOI
|
27 |
Varona R, Pérez P, Durán A. 1983. Effect of papulacandin B on β-glucan synthesis in Schizosaccharomyces pombe. FEMS Microbiol. Lett. 20: 243-247.
|
28 |
Shedletzky E, Unger C, Delmer DP. 1997. A microtiter-based fluorescence assay for (1,3)-β-glucan synthases. Anal. Biochem. 249: 88-93.
DOI
|
29 |
Vandeputte P, Ferrari S, Coste AT. 2012. Antifungal resistance and new strategies to control fungal infections. Int. J. Microbiol. 2012: 1-26.
DOI
|
30 |
Sung B, Chung HS, Kim M, Kang YJ, Kim DH, Hwang SY, et al. 2015. Cytotoxic effects of solvent-extracted active components of Salvia miltiorrhiza Bunge on human cancer cell lines. Exp. Ther. Med. 9: 1421-1428.
DOI
|
31 |
Wang S, Beechem JM, Gratton E, Glaser M. 1991. Orientational distribution of 1,6-diphenyl-1,3,5-hexatriene in phospholipid vesicles as determined by global analysis of frequency domain fluorimetry data. Biochemistry 30: 5565-5572.
DOI
|
32 |
White TC, Marr KA, Bowden RA. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11: 382-402.
|
33 |
Zhao J, Lou J, Mou Y, Li P, Wu J, Zhou L. 2011. Diterpenoid tanshinones and phenolic acids from cultured hairy roots of Salvia miltiorrhiza Bunge and their antimicrobial activities. Molecules 16: 2259-2267.
DOI
|